Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
venous, arterial or microvascular thrombosis or obstetric events in the presence of …

Antiphospholipid syndrome (APS) encompasses a wide spectrum of disease manifestations
that may prevail in the form of venous or arterial thrombosis or lead to pregnancy …

The antiphospholipid syndrome (APS) is an autoimmune systemic disease characterized by
a hypercoagulable state secondary to the presence of antiphospholipid antibodies (aPL) …

Antiphospholipid syndrome (APS) is the most common cause of acquired thrombophilia, but
experimental and clinical evidence accumulated over the years suggest that the clinical …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by venous
thromboembolism, arterial thrombosis, and obstetric morbidities in the setting of persistently …

Antiphospholipid syndrome (APS) is an acquired autoimmune disorder characterized by
venous or arterial thrombosis, and recurrent pregnancy morbidity in the presence of …

Antiphospholipid syndrome (APS) is a systemic autoimmune disease associated with
arterial and venous thrombotic events and recurrent fetal loss. Cardiac manifestations in …

A major cause of morbidity and mortality in the context of the antiphospholipid syndrome
(APS) is the occurrence of thrombotic events. Besides the pathogenic roles of …

Antiphospholipid syndrome (APS) is a multisystem autoimmune disease most commonly
associated with recurrent arterial and venous thromboembolism and recurrent fetal loss …

Eur J Clin Invest 2010; 40 (5): 451–464 Abstract Background Antiphospholipid syndrome
(APS) is a systemic autoimmune vascular disease characterized by recurrent thrombotic …